The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.

Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incid...

Full description

Bibliographic Details
Main Authors: Cheuk-Chun Szeto, Bonnie C H Kwan, Kai-Ming Chow, Phyllis M S Cheng, Vickie W K Kwong, Agnes S M Choy, Man-Ching Law, Chi-Bon Leung, Philip K T Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4625015?pdf=render
id doaj-1acf66b574964583b3d832a7406a83ba
record_format Article
spelling doaj-1acf66b574964583b3d832a7406a83ba2020-11-24T20:50:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014142510.1371/journal.pone.0141425The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.Cheuk-Chun SzetoBonnie C H KwanKai-Ming ChowPhyllis M S ChengVickie W K KwongAgnes S M ChoyMan-Ching LawChi-Bon LeungPhilip K T LiPrevious studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV.After 52 weeks, Intervention Group had higher overhydration (3.1 ± 2.6 vs 1.9 ± 2.2 L, p = 0.045) and extracellular water volume (17.7 ± 3.9 vs 15.8 ± 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 ± .0.61 vs 0.90 ± 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 ± 0.77 vs 4.91 ± 0.95 mg/dL, p < 0.0001).Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study.ClinicalTrials.gov NCT00966615.http://europepmc.org/articles/PMC4625015?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Cheuk-Chun Szeto
Bonnie C H Kwan
Kai-Ming Chow
Phyllis M S Cheng
Vickie W K Kwong
Agnes S M Choy
Man-Ching Law
Chi-Bon Leung
Philip K T Li
spellingShingle Cheuk-Chun Szeto
Bonnie C H Kwan
Kai-Ming Chow
Phyllis M S Cheng
Vickie W K Kwong
Agnes S M Choy
Man-Ching Law
Chi-Bon Leung
Philip K T Li
The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
PLoS ONE
author_facet Cheuk-Chun Szeto
Bonnie C H Kwan
Kai-Ming Chow
Phyllis M S Cheng
Vickie W K Kwong
Agnes S M Choy
Man-Ching Law
Chi-Bon Leung
Philip K T Li
author_sort Cheuk-Chun Szeto
title The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
title_short The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
title_full The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
title_fullStr The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
title_full_unstemmed The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition--A Randomized Control Trial.
title_sort effect of neutral peritoneal dialysis solution with low glucose-degradation-product on the fluid status and body composition--a randomized control trial.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied.We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV.After 52 weeks, Intervention Group had higher overhydration (3.1 ± 2.6 vs 1.9 ± 2.2 L, p = 0.045) and extracellular water volume (17.7 ± 3.9 vs 15.8 ± 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 ± .0.61 vs 0.90 ± 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 ± 0.77 vs 4.91 ± 0.95 mg/dL, p < 0.0001).Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study.ClinicalTrials.gov NCT00966615.
url http://europepmc.org/articles/PMC4625015?pdf=render
work_keys_str_mv AT cheukchunszeto theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT bonniechkwan theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT kaimingchow theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT phyllismscheng theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT vickiewkkwong theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT agnessmchoy theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT manchinglaw theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT chibonleung theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT philipktli theeffectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT cheukchunszeto effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT bonniechkwan effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT kaimingchow effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT phyllismscheng effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT vickiewkkwong effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT agnessmchoy effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT manchinglaw effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT chibonleung effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
AT philipktli effectofneutralperitonealdialysissolutionwithlowglucosedegradationproductonthefluidstatusandbodycompositionarandomizedcontroltrial
_version_ 1716804971640389632